卖什么
AI法规合规。
商业模式拆解
买家：谁掌握预算？
未核实Heads of safety/pharmacovigilance, regulatory, clinical and AI/digital innovation at regulated enterprises.
触发点：什么让他们现在购买？
AI initiatives stall at regulatory (GxP) requirements; fragmented safety, regulatory and clinical systems.
工作流：什么输入变成什么输出？
Converts regulations/SOPs into machine-readable compliance logic, orchestrates AI workflows across systems with compliance enforced at each step, and produces continuous audit-ready evidence; use cases: pharmacovigilance case processing, regulatory submissions, clinical development.
经济账：省了什么，怎么收费？
Claims faster validation/submission timelines, lower cost via automated compliance enforcement, continuous audit readiness; commercial model not stated.
渠道：怎么接触到客户？
Demo-led enterprise sales ("Book a Demo"); recently announced seed round.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-04-23 | — | $8.6M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.